• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.

作者信息

Entenza J M, Fluckiger U, Glauser M P, Moreillon P

机构信息

Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

J Infect Dis. 1994 Jul;170(1):100-9. doi: 10.1093/infdis/170.1.100.

DOI:10.1093/infdis/170.1.100
PMID:8014483
Abstract

The natural history and treatment of experimental endocarditis due to heterogeneous and homogeneous methicillin-resistant Staphylococcus epidermidis was investigated. Amoxicillin/clavulanate or vancomycin were administered for 3 days via a computerized pump to mimic human drug kinetics in animals. After challenge with the minimum inoculum producing 90% of infections (ID90), bacteria in the vegetations grew logarithmically for 16 h. Then, bacterial densities stabilized (at approximately 10(8) cfu/g) and growth rates sharply declined. Both regimens cured > or = 60% of endocarditis (due to heterogeneous or homogeneous bacteria) when started 12-16 h after infection, although the bacterial densities in the vegetations had increased by 20 times in between. In contrast, treatment started after 24 h failed in most animals, while bacterial densities had not increased any more. Thus, while both regimens were equivalent, the therapeutic outcome was best predicted by growth rates in the vegetations, not by bacterial densities. These observations highlight the importance of phenotypic tolerance developing in vivo.

摘要

相似文献

1
Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
J Infect Dis. 1994 Jul;170(1):100-9. doi: 10.1093/infdis/170.1.100.
2
Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.阿莫西林-克拉维酸、氯唑西林和万古霉素对大鼠甲氧西林敏感和耐甲氧西林金黄色葡萄球菌心内膜炎的疗效比较
J Infect Dis. 1989 May;159(5):989-93. doi: 10.1093/infdis/159.5.989.
3
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.达托霉素对耐甲氧西林和糖肽中介金黄色葡萄球菌引起的实验性心内膜炎有效。
Antimicrob Agents Chemother. 2010 Jul;54(7):2781-6. doi: 10.1128/AAC.01011-09. Epub 2010 Apr 26.
4
Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.阿莫西林/克拉维酸在大鼠实验性金黄色葡萄球菌心内膜炎中的疗效。
J Antimicrob Chemother. 1991 Jan;27(1):117-26. doi: 10.1093/jac/27.1.117.
5
The in-vivo activity of co-amoxiclav with netilmicin against experimental methicillin and gentamicin resistant Staphylococcus epidermidis infection in rabbits.阿莫西林克拉维酸与奈替米星联合应用对兔实验性耐甲氧西林和耐庆大霉素表皮葡萄球菌感染的体内活性。
J Antimicrob Chemother. 1993 Jan;31(1):129-38. doi: 10.1093/jac/31.1.129.
6
Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.亚胺培南治疗实验性表皮葡萄球菌心内膜炎
Antimicrob Agents Chemother. 1986 May;29(5):748-52. doi: 10.1128/AAC.29.5.748.
7
The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.阿莫西林/克拉维酸(奥格门汀)治疗严重葡萄球菌感染的疗效。
J Chemother. 1994 Apr;6 Suppl 2:51-7.
8
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.耐甲氧西林表皮葡萄球菌实验性心内膜炎的治疗
J Lab Clin Med. 1982 Jul;100(1):94-104.
9
Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.替考拉宁与万古霉素治疗耐甲氧西林表皮葡萄球菌所致实验性心内膜炎的比较。
J Infect Dis. 1986 Jul;154(1):69-75. doi: 10.1093/infdis/154.1.69.
10
Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis.
J Antimicrob Chemother. 1989 Jan;23(1):117-21. doi: 10.1093/jac/23.1.117.

引用本文的文献

1
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.LB11058,一种新型头孢菌素,对青霉素结合蛋白2a具有高亲和力,且在由均匀耐甲氧西林金黄色葡萄球菌引起的实验性心内膜炎中具有活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4322-7. doi: 10.1128/AAC.48.11.4322-4327.2004.
2
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.奎奴普丁-达福普汀与万古霉素联合应用对耐甲氧西林金黄色葡萄球菌的体外抗菌活性及在实验性心内膜炎中的疗效,以及与对大环内酯类、林可酰胺类和链阳菌素B型抗生素的交叉耐药性的关系。
Antimicrob Agents Chemother. 2002 Sep;46(9):3061-4. doi: 10.1128/AAC.46.9.3061-3064.2002.
3
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.BAL9141,一种新型广谱头孢菌素,对耐甲氧西林金黄色葡萄球菌具有活性,用于治疗实验性心内膜炎。
Antimicrob Agents Chemother. 2002 Jan;46(1):171-7. doi: 10.1128/AAC.46.1.171-177.2002.
4
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.莫西沙星、环丙沙星和万古霉素对表达不同程度环丙沙星耐药性的耐甲氧西林金黄色葡萄球菌所致实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2001 Nov;45(11):3076-83. doi: 10.1128/AAC.45.11.3076-3083.2001.
5
Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.曲伐沙星治疗实验性葡萄球菌或链球菌性心内膜炎的疗效。
Antimicrob Agents Chemother. 1999 Jan;43(1):77-84. doi: 10.1128/AAC.43.1.77.
6
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.Y-688,一种对耐喹诺酮金黄色葡萄球菌有效的新型喹诺酮:在实验性心内膜炎中缺乏体内疗效。
Antimicrob Agents Chemother. 1998 Aug;42(8):1889-94. doi: 10.1128/AAC.42.8.1889.
7
Handwashing patterns in primary pediatric community clinics.
Infection. 1998 Jan-Feb;26(1):45-7. doi: 10.1007/BF02768754.
8
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.RP 59500对由对红霉素敏感和耐药的同基因草绿色链球菌对引起的实验性心内膜炎的预防作用。
Antimicrob Agents Chemother. 1995 Jul;39(7):1425-9. doi: 10.1128/AAC.39.7.1425.
9
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.用RP 59500治疗对红霉素敏感或耐药的耐甲氧西林金黄色葡萄球菌引起的实验性心内膜炎。
Antimicrob Agents Chemother. 1995 Jul;39(7):1419-24. doi: 10.1128/AAC.39.7.1419.